HealthLynked Corp. (HLYK)
OTCMKTS · Delayed Price · Currency is USD
4.197
-1.953 (-31.76%)
At close: Jan 23, 2026
HealthLynked Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2.37 | 2.98 | 5.66 | 5.84 | 6.48 | 5.37 | Upgrade |
Other Revenue | 0 | 0.03 | 0.06 | 0.02 | 0.01 | - | Upgrade |
| 2.37 | 3.01 | 5.72 | 5.86 | 6.5 | 5.37 | Upgrade | |
Revenue Growth (YoY) | -28.51% | -47.43% | -2.32% | -9.83% | 21.09% | 33.51% | Upgrade |
Cost of Revenue | 1.37 | 2.09 | 3.37 | 3.8 | 3.72 | 2.73 | Upgrade |
Gross Profit | 1 | 0.92 | 2.35 | 2.06 | 2.78 | 2.64 | Upgrade |
Selling, General & Admin | 2.13 | 3.04 | 3.62 | 4.58 | 4.93 | 3.06 | Upgrade |
Other Operating Expenses | 1.1 | 1.56 | 2.21 | 2.57 | 2.35 | 2.4 | Upgrade |
Operating Expenses | 3.34 | 4.88 | 6.18 | 7.97 | 8.11 | 5.71 | Upgrade |
Operating Income | -2.33 | -3.96 | -3.83 | -5.91 | -5.33 | -3.07 | Upgrade |
Interest Expense | -1.51 | -1.48 | -0.5 | -0.08 | -0.02 | -0.78 | Upgrade |
Other Non Operating Income (Expenses) | -0 | - | - | -0.11 | - | 0.74 | Upgrade |
EBT Excluding Unusual Items | -3.85 | -5.45 | -4.33 | -6.1 | -5.35 | -3.11 | Upgrade |
Impairment of Goodwill | - | - | -0.32 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.28 | Upgrade |
Asset Writedown | - | -0.72 | - | -2.75 | - | - | Upgrade |
Legal Settlements | - | - | - | - | - | -0.71 | Upgrade |
Other Unusual Items | 0.01 | 0.03 | 1.04 | 0.78 | -5.35 | -1.65 | Upgrade |
Pretax Income | -3.83 | -6.13 | -3.61 | -8.07 | -10.7 | -5.76 | Upgrade |
Earnings From Continuing Operations | -3.83 | -6.13 | -3.61 | -8.07 | -10.7 | -5.76 | Upgrade |
Earnings From Discontinued Operations | - | - | 2.6 | -0.75 | 0.29 | - | Upgrade |
Net Income | -3.83 | -6.13 | -1.01 | -8.82 | -10.41 | -5.76 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | 0.35 | 0.35 | 0.45 | Upgrade |
Net Income to Common | -3.83 | -6.13 | -1.01 | -9.17 | -10.77 | -6.2 | Upgrade |
Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 2 | 1 | Upgrade |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 2 | 1 | Upgrade |
Shares Change (YoY) | 1.41% | 7.09% | 8.00% | 8.35% | 57.30% | 44.18% | Upgrade |
EPS (Basic) | -1.36 | -2.18 | -0.39 | -3.77 | -4.79 | -4.34 | Upgrade |
EPS (Diluted) | -1.36 | -2.18 | -0.39 | -3.77 | -4.87 | -4.34 | Upgrade |
Free Cash Flow | -2.04 | -3.5 | -4.15 | -4.39 | -3.79 | -2.14 | Upgrade |
Free Cash Flow Per Share | -0.72 | -1.24 | -1.58 | -1.80 | -1.69 | -1.50 | Upgrade |
Gross Margin | 42.32% | 30.48% | 41.05% | 35.15% | 42.72% | 49.16% | Upgrade |
Operating Margin | -98.19% | -131.69% | -66.96% | -100.95% | -82.05% | -57.25% | Upgrade |
Profit Margin | -161.50% | -203.81% | -17.69% | -156.52% | -165.71% | -115.58% | Upgrade |
Free Cash Flow Margin | -85.84% | -116.23% | -72.46% | -74.88% | -58.32% | -39.93% | Upgrade |
EBITDA | -2.23 | -3.85 | -3.71 | -5.08 | -4.5 | -2.82 | Upgrade |
EBITDA Margin | -93.82% | -127.86% | -64.80% | -86.79% | -69.31% | -52.64% | Upgrade |
D&A For EBITDA | 0.1 | 0.12 | 0.12 | 0.83 | 0.83 | 0.25 | Upgrade |
EBIT | -2.33 | -3.96 | -3.83 | -5.91 | -5.33 | -3.07 | Upgrade |
EBIT Margin | -98.19% | -131.69% | -66.96% | -100.95% | -82.05% | -57.25% | Upgrade |
Revenue as Reported | 2.37 | 3.01 | 5.72 | 5.86 | 6.5 | 6.13 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.